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a b s t r a c t
During brain morphogenesis, the neuroepithelium must fold in speciﬁc regions to delineate functional
units, and give rise to conserved embryonic brain shape. Individual cell shape changes are the basis for
the morphogenetic events that occur during whole tissue shaping. We used the zebraﬁsh to study the
molecular mechanisms that regulate the ﬁrst fold in the vertebrate brain, the highly conserved
midbrain-hindbrain boundary (MHB). Since the contractile state of the neuroepithelium is tightly
regulated by non-muscle myosin II (NMII) activity, we tested the role of NMIIA and NMIIB in regulating
cell shape changes that occur during MHB morphogenesis. Using morpholino knockdown, we show that
NMIIA and NMIIB are both required for normal MHB tissue angle. Quantiﬁcation of cell shapes revealed
that NMIIA is required for the shortening of cells speciﬁcally at the MHB constriction (MHBC), while
NMIIB is required for the proper width of cells throughout the MHB region. NMIIA and NMIIB
knockdown also correlated with abnormal distribution of actin within the cells of the MHBC. Thus,
NMIIA and NMIIB perform distinct functions in regulating cell shape during MHB morphogenesis.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Morphogenesis is a key developmental process that shapes all
organs and is required for proper organ function. Regulation of
individual cell shape changes are at the core of morphogenetic
events which together give rise to whole tissue shape (Heisenberg
and Bellaiche, 2013; Lecuit and Lenne, 2007). During vertebrate
brain development, neuroepithelial cells of the neural tube fold in
speciﬁc regions giving rise to the characteristic embryonic verte-
brate brain shape. The fold at the midbrain-hindbrain boundary
(MHB) functions as a crucial organizing center for the developing
embryo and is one of the earliest and most highly conserved folds
in the vertebrate brain (Brand et al., 1996; Rhinn and Brand, 2001).
Given the high degree of conservation of the MHB across verte-
brate species in terms of function and form, understanding the
molecular mechanisms underlying its development is critical to
our understanding of brain morphogenesis.
Our previous work characterized the basic morphogenetic
events that occur to form this highly conserved fold in the zebraﬁsh
(Gutzman et al., 2008). We demonstrated that cell shortening and
basal constriction occur in cells at the point of deepest constriction
of the MHB, the midbrain-hindbrain boundary constriction (MHBC)
(Gutzman et al., 2008). While we previously determined that basal
constriction is dependent on laminin, the mechanisms that regulate
cell shortening at the MHBC are unknown.
Neuroepithelial cell shape and brain morphogenesis are also
dependent upon the contractile state of the neuroepithelium
(Gutzman and Sive, 2010). This contractile state is tightly regulated
by non-muscle myosin II (NMII) activity. We demonstrated that
mypt1, the myosin phosphatase regulatory subunit, is required for
cell shape regulation during hindbrain morphogenesis and impor-
tant for regulating the activity of NMII (Gutzman and Sive, 2010).
Myosin phosphatase dephosphorylates the myosin regulatory light
chain (MRLC) where MRLC, in the phosphorylated state, activates
the contraction of NMII. NMII proteins are critical regulators of cell
motility, cytokinesis, polarity, and adhesion. In addition, it has
been established in multiple systems that cell shape is critically
dependent upon NMII function (Vicente-Manzanares et al., 2009).
Depending on the tissue and cell type, NMIIA and NMIIB may
have either overlapping or distinct roles during embryonic develop-
ment (Wang et al., 2011). For example, NMIIA and NMIIB knockout
mice have different phenotypes. NMIIA knockouts are embryonic
lethal and die before gastrulation due to defects in cell-cell adhesion
(Conti et al., 2004). In contrast, NMIIB knockout mice display heart
defects, hydrocephalus, and abnormal neuronal migration (Ma et al.,
2007; Ma et al., 2004). In migrating cells, NMIIA and NMIIB have
different localization and function, which depend on the rigidity of
the speciﬁc migratory substrate (Raab et al., 2012).
Given that non-muscle myosins have important roles in reg-
ulating cell and tissue shape, we hypothesized that NMIIA and
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NMIIB regulate cell shape changes that occur to form the MHBC.
Here we used the zebraﬁsh MHB as a model for determining the
molecular mechanisms regulating the initial cell shape changes
that occur during brain morphogenesis. We discovered distinct
roles for NMIIA and NMIIB in MHB morphogenesis using live
imaging to quantify changes in cell shape. We determined that
NMIIA controls the length of the cells speciﬁcally at the MHBC,
while NMIIB regulates the width of cells throughout the MHB
tissue. Thus NMIIA and NMIIB perform non-redundant functions
in regulating the morphogenesis of the MHB.
Materials and methods
Zebraﬁsh maintenance and husbandry
Standard procedures were used for zebraﬁsh maintenance and
husbandry (Kimmel et al., 1995; Westerﬁeld, 2000). Wild-type AB
zebraﬁsh embryos were used for all experiments. Embryos were
staged according to Kimmel et al., 1995. For all experiments somite
number was counted to allow for consistent staging comparisons
and to eliminate the possibility of phenotypes resulting from
developmental delay. The following equivalent staging points
were used; 18 somite stage (ss) is equal to 18 hours post fertiliza-
tion (hpf); 22 ss is equal to 20 hpf; and 24 ss is equal to 22 hpf.
Embryonic gene expression analysis
For all of our studies we used the following sequence information
from Zebraﬁsh Ensembl (Flicek et al., 2013). myh9a located on
the reverse strand of chromosome 6, ENSDART00000149823.myh9b
located on the reverse strand of chromosome 3, ENSDART000
00137105. myh10 homolog was found to be located on the forward
strand of a different region of chromosome 6, ENSDART0000
0151114. RT-PCR was conducted on RNA isolated from wild-type
embryos over time. Primers used include: myh9a forward primer
(50–AAATTCAGCAAGGTGGAGGA-30); myh9a reverse primer (50–
TTGGTGTTTTCGGTTTTTCC-30); myh9b forward primer: (50–CCTG
CCCATCTACTCAGAGG-30); myh9b reverse primer (50–TGTGGAAGG
TTCGCTCTTCT-30); myh10 forward primer (50–CTTCTGAACGGCAT
GGATTT-30); myh10 reverse primer (50–TTGGCATTTCCAAAGGATTC-
30); Ef1α forward primer: (50–GATGCACCACGAGTCTCTGA-30); Ef1α
reverse primer: (50–TGATGACCTGAGCGTTGAAG-30).
Antisense morpholino oligonucleotide injections
Splice site-blocking morpholino antisense oligonucleotides
(morpholino: MO) were used for all knockdown experiments. MO
details for each gene are as follows: myh9a MO (50–AGCAAGAGA-
GACTTACAAATCGAGA-30; Gene Tools) that targets intron1-EXON2.
myh9b MO (50–ATGTCTGAAACAGTCGTTTACAAGC-30; Gene Tools)
that targets EXON6-intron6. myh10 MO (50–CTTCACAAATGTGGTCT-
TACCTTGA-30; Gene Tools) that targets EXON2-intron2. mypt1 MO
(50–ATTTTTTGTGACTTACTCAGCGATG-30; Gene Tools) that targets
EXON2-intron 2 (Gutzman and Sive, 2010). Standard control MO
(50–CCTCTTACCTCAGTTACAATTTATA-30) was used where indicated
(Gene Tools). Zebraﬁsh p53 MO (50–GCGCCATTGCTTTTGCAA-
GAATTG-30; Gene Tools) was only used in conjunction with the
myh9b MO (Robu et al., 2007). For all MO knockdown experiments,
the following concentrations were used and injected into one cell
stage embryos either alone or in conjunction with membrane
targeting GFP (mGFP). 4 ng myh9a MO, 3 ng myh9b MO with 3 ng
p53 MO, 3 ng myh10 MO, 5 ng mypt1 MO. The concentration of
control MO was equal to the highest concentration of any experi-
mental MO used in that experiment. Up to 6 ng of myh9a MO was
used with no obvious brain phenotype. All confocal evaluation for
myh9a MO was conducted at 4 ng.
In situ hybridization
In situ hybridization was conducted according to standard proce-
dures. RNA probes were designed to unique UTR sequences due to the
high sequence similarities in the coding regions of these genes (probe
regions are shown in Fig. 1). The myh9a probe was cloned from the
30end into the 30 UTR of myh9a from 24 hpf wild type embryos using
the following primers. myh9a primer 30end forward (50–TGGAGGA-
GACTGAGGAGGAA-30), myh9a primer 30UTR reverse (50–GAACAG;
GCCGAATGAAACAT-30) resulting in a 502 bp probe. The myh9b
in situ probe was cloned from the 50UTR into the 50end of myh9b
from 24 hpf wild type embryos using the following primers. myh9b
primer 50UTR forward (50–GTGGAAGAGGGAGGGAAGAG-30), myh9b
primer 50end reverse (50–AAGGCACCCACACTAGCTTC-30) resulting in a
290 bp probe. The PCR fragments above were subcloned into pGEM
using the pGEM T-Easy Vector System Kit (Promega) for probe
synthesis. The myh10 in situ probe was made from Image clone
8801976 from Open Biosystems and is located in the 30UTR of the
gene and results in an 810 bp probe. Sense and antisense probes were
made and used for each in situ experiment to test for speciﬁcity.
Actin staining
Embryos were ﬁxed in 4% paraformaldehyde for 2 h at room
temperature or overnight at 4 1C and washed in PBT. Embryos
were incubated at 4 1C overnight in Alexa Fluor 488 phalloidin
(Invitrogen A12379) 1:40 in PBT, washed 3X in PBT, mounted in
glycerol, and imaged using a Nikon CS2 laser-scanning confocal
microscope. Images were analyzed with Nikon Elements software
and Photoshop (Adobe).
Non-muscle myosin IIA and IIB immunostaining
Embryos were ﬁxed in Dents for 2 h at room temperature,
deyolked, blocked overnight at 4 1C, and then washed in PBT.
Embryos were incubated in primary antibody (anti-myosin IIA
antibody raised in rabbit, Sigma-Aldrich, M8064, 1:500; and anti-
myosin IIB antibody raised in mouse, Santa Cruz Biotechnology, sc-
376942, 1:100) overnight at 4 1C, washed in PBT, then incubated in
secondary antibody (Alexa Fluor 488 goat anti-rabbit, Life Technol-
ogies, 1:500 and/or Alexa Fluor 555 goat anti-mouse, Life Technol-
ogies, 1:500). Embryos were ﬂat mounted in glycerol, imaged using
a Nikon CS2 laser-scanning confocal microscope, and images were
analyzed with Nikon Elements and Photoshop (Adobe) software.
Imaging
All live confocal imaging was conducted as previously
described (Graeden and Sive, 2009) using a Nikon CS2 scanning
confocal and Nikon Elements software. Brieﬂy, embryos were co-
injected at the one-cell stage with membrane GFP (mGFP) mRNA
(GFP-CAXX) and the morpholinos indicated. Live embryos were
then mounted in agarose wells on a slide and oriented for imaging.
A z-series of images was taken for each embryo. Live confocal
images presented in each ﬁgure are single slices taken from a
z-series of images approximately 15–20 μm into the tissue from
the dorsal surface. Brightﬁeld and in situ hybridization imaging
was conducted using an Olympus SZX12 stereomicroscope with an
Olympus DP72 camera. All images were processed using Nikon
Elements software or Photoshop (Adobe).
Cell shape analysis
For all cell measurements, single cells were selected based on
the ability to see one single cell spanning the entire width of the
neuroepithelium from apical to basal in a single z-plane in the
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region of interest. Cell length was determined using the Nikon
Imaging Systems (NIS) Elements software measurement tool by
measuring from apical to basal of a single cell spanning the
neuroepithelium. The cell width measurement was obtained from
the NIS-Elements software as an average width of a cell. Single
cells were manually outlined in a single z-series image to create an
object. Then the NIS-Elements software determined the average
width of the object (cell) by ﬁrst calculating the area and the
perimeter of the object (cell). The software then calculated the
length of the object using the formula: Length¼(PerimeterþSqrt
(Perimeter2–16nArea))/4. The width of the object was in turn
calculated using the formula: Width¼Area/Length.
Statistical analysis
Statistical analysis for all ANOVA data presented was computed
using R-3.0.1.
Results
Expression of non-muscle myosin IIA and IIB during embryonic
development
Non-muscle myosins are known to be key regulators of cell
shape during embryonic morphogenesis (Lecuit and Lenne, 2007;
Vicente-Manzanares et al., 2009). We hypothesized that these
proteins also play an integral role in shaping the cells that
contribute to the MHB tissue fold. In order to test this hypothesis
we ﬁrst determined the zebraﬁsh homologs of human non-muscle
myosin II proteins. Zebraﬁsh have two homologs of human MYH9
(myh9a and myh9b) encoding for NMIIA, one homolog for MYH10
(myh10) which encodes for NMIIB, and one homolog for MYH14
(myh14), which encodes for NMIIC. According to the current
zebraﬁsh genome assembly, the sequence homology for myh9a
and myh9b is 77% and 79% respectively, compared to the human
MYH9 (Flicek et al., 2013). Zebraﬁsh myh10 is 90% similar to the
human homolog, while myh14 is only 62% similar to the human
homolog. It has been demonstrated in the mouse that all three
isoforms are expressed broadly throughout the embryo; however,
there are tissues that express relatively higher levels of one
isoform compared to others (Golomb et al., 2004). myh14 appears
to have the lowest expression level in the developing mouse brain
(Golomb et al., 2004), and has the lowest sequence homology from
human to zebraﬁsh; therefore, we did not investigate the role of
NMIIC in cell shape changes during MHB morphogenesis in the
zebraﬁsh.
Diagrams of the three zebraﬁsh genes investigated in this study
are shown (Fig. 1A). Using RT-PCR we conﬁrmed that all three
genes were expressed embryonically during the time of MHB
development (Fig. 1B). We further analyzed gene expression using
in situ hybridization to determine the localization of expression
Fig. 1. myh9a, myh9b, and myh10 are expressed during the time of MHB morphogenesis. (A) Diagram of the zebraﬁsh myh9a, myh9b, and myh10 genes. Domain regions are
highlighted. Regions ampliﬁed for RT-PCR time course expression are shown with arrows (primer details can be found in “Materials and Methods”). Asterisks indicate the
regions of the full length myh9a and myh9b in the current Ensembl zebraﬁsh genome that have not been completely annotated. (B) RT-PCR analysis of myh9a, myh9b, and
myh10 over a time course of embryonic development spanning MHB morphogenesis. EF1αwas used as a control. Primer locations are indicated in panel A. (C) Time course of
gene expression by in situ hybridization for myh9a, myh9b, and myh10 in the developing embryo from 4 hpf–24 hpf. Each gene is shownwith the antisense probe expression
pattern and sense control.
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within the developing embryo (Fig. 1C). We found low levels of
expression for myh9a maternally (4 hpf) and at early stages
(12 hpf). There was some localized expression of myh9a within
the forebrain, eyes, and tail between 18 and 24 hpf. Non-speciﬁc
staining for myh9a was detected within the brain ventricle space
and in the yolk in both antisense and sense controls. myh9a did
not have obvious expression in the neuroepithelium of the MHB
region during morphogenesis. myh9b was found to be expressed
maternally (4 hpf) and expression was detected throughout the
whole embryo and brain at each time point analyzed. myh10 had a
low level of maternal expression at 4 hpf; however, by 12 hpf
myh10 was also found to be expressed throughout the whole
embryo and brain. Together these data indicate that the zebraﬁsh
non-muscle myosin II genes myh9b and myh10 are expressed
during the time of MHB morphogenesis and are found throughout
the embryo and brain. While myh9a is also expressed, it does not
appear to be as highly localized to the brain or MHB region as
myh9b or myh10 at these times. These data are consistent with the
reported expression patterns for myh9 and myh10 during mouse
embryonic development (Golomb et al., 2004). Next, we investi-
gated the role for myh9a, myh9b, and myh10 in regulating the cell
shape changes that are required for the formation of the MHB fold.
Characterization of early MHB morphogenesis and cell shape changes
In order to better characterize the initial tissue and cell shape
changes that lead to the MHB tissue fold, we performed detailed
analysis of wild type MHB development during early stages of
MHB formation when cells are shortening (Gutzman et al., 2008).
We injected wild type embryos with membrane GFP (mGFP)
mRNA and imaged the developing MHB in live embryos using
scanning confocal microscopy at the somite stages indicated
(Fig. 2). We quantiﬁed changes in the tissue over this time frame
by analyzing tissue angle, cell length, and cell width. We found
that the angle of the fold changes from 140 degrees to less than
100 degrees between 18 and 24 somite stage (ss) (Fig. 2A–D). We
found that cells at the MHBC shorten from 50 μm to less than
40 μm during this time frame (Fig. 2E). We also found that cells
outside the MHBC get slightly shorter during this time; however,
there is still a large difference in cell length at the MHBC compa-
red to cells outside (Fig. 2F). By 24 ss cells at the MHBC are
approximately 75% of the length of the outside cells (Fig. 2G)
which is consistent with our previous ﬁndings (Gutzman et al.,
2008). Importantly, we also discovered that the width of the cells
changes between 22 and 24 ss (Fig. 2H) and cells in the MHB
Fig. 2. Quantiﬁcation of wild type tissue and cell shape changes during MHB morphogenesis between 18 and 24 ss. (A–C) Live confocal imaging of wild type embryos
injected with mGFP and imaged at the stages indicated. (A’–C’) Magniﬁcations of images in A–C with individual cells outlined at the MHBC and posterior to the MHBC
towards the hindbrain. (D) Quantiﬁcation of the MHB angle on the basal side of the neuroepithelium (see dotted lines in A–C). (E) Measurement of neural tube width as a
representation of cell length in cells at the MHBC over time. (F) Measurement of neural tube width as a representation of cell length in cells 40 μm posterior to the MHBC
over time. (G) Changes in the percentage of cell shortening for cells at the MHBC compared to cells 40 μm outside the MHBC over time. (H) Quantiﬁcation of cell width
measurements over time. Arrowheads indicate MHBC. Asterisks in A–C indicate cells outlined in the images below (A’–C’). One-way ANOVAwith multiple t-test comparisons
was performed to determine signiﬁcance, asterisks indicate po0.001. Results are shown as7s.e.m. 18 ss, n¼9; 22 ss, n¼11; 24 ss, n¼11. Scale bars: 25 μm.
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region get narrower as the morphology of the MHB is changing
and the MHBC is forming.
myh9b and myh10 are required for MHB development
In order to deﬁne the role for NMIIA and NMIIB in embryonic
MHB morphogenesis, we conducted knockdown experiments using
splice-site targeting, antisense oligonucleotide morpholino (MO)
knockdown of myh9a, myh9b, and myh10. Splice targeting morpho-
linos were chosen due to the essential requirement for non-muscle
myosins during early development and cell division (Conti et al.,
2004; Ma et al., 2007; Maciver, 1996; Urven et al., 2006). We were
able to carefully titrate the concentration of each splice targeting
morpholino to prevent abnormal levels of cell death while main-
taining normal levels of cells division, which allowed us to determine
the role for these proteins in regulating cell shape during morpho-
genesis. Splice blocking morpholinos were conﬁrmed at the concen-
trations used for all of the experiments presented here using RT-PCR
or Western blot analysis (Fig. S1).
Embryos were injected with morpholinos at the one-cell stage
and analyzed for gross embryonic phenotypes and for overall brain
morphology at 24 ss using brightﬁeld microscopy. Although we
focused speciﬁcally on brain morphogenesis defects and cell shape
changes at the MHB for this study, we did observe other gross
phenotypes in morpholino injected embryos (Fig. S2). myh9b
morphants demonstrated somite defects, abnormal tail curvature,
pigmentation defects, heart abnormalities, slight edema, and abnor-
mal eye and ear formation. myh10 morphants had abnormal body
axis curvature, heart abnormalities, and abnormal eye develop-
ment. myh9a morphants injected with our splice site targeting MO
did not appear to have any observable gross morphology defects
with the concentrations of morpholino tested (Fig. S2). This is in
contrast to the studies by Muller et al. where they demonstrated
that knockdown ofmyh9a (previously called zmyh9 andmyh9-like2)
using a MO targeting the 50-untranslated region and translational
start site, leads to abnormal development of the glomerulus and
causes gross embryonic edema at ﬁve days post fertilization (Muller
et al., 2011). In those studies Muller et al. did not investigate the role
of the other zebraﬁsh myh9 gene, myh9b (previously called myhz9
and myh9-like1). This difference in overall gross phenotype for
myh9a knockdown between our studies and Muller et al. is likely
due to the timing of phenotypic analysis, the nature of the morp-
holinos utilized, and their respective target sequences.
Analysis of overall MHB morphology in control MO injected
embryos at 24 ss showed normal formation of the MHB, visible with
a clear and distinct fold in the tissue at the point of deepest
constriction (MHBC) and normal openings in the midbrain and
hindbrain ventricles (Fig. 3A). These results are consistent with our
previous reports (Gutzman et al., 2008). A morpholino designed
speciﬁcally to target onlymyh9a did not result in any visible abnormal
MHB or brain phenotype when imaged with brightﬁeld microscopy
(Fig. 3B). In contrast, embryos injected with the myh9b MO or the
myh10 MO had abnormal MHB development. myh9b morphants did
not have a sharp fold in the tissue at the point of deepest constriction,
instead the fold was a curved shape (Fig. 3C). myh10 morphants,
similar to myh9b morphants, failed to form a sharp tissue bend at the
MHB (Fig. 3D). myh10 morphants also had decreased midbrain
ventricle opening (Fig. 3D). We have previously shown that abnormal
brain ventricle inﬂation, due to lack of cerebrospinal ﬂuid as found in
the snakehead mutant, did not affect cell shape at the MHB (Gutzman
et al., 2008). Therefore, the myh10 morphant ventricle defect is likely
due to abnormal dorsolateral hinge-point formation which is also
dependent on non-muscle myosin II (Nyholm et al., 2009). Knock-
down of both myh9a and myh9b together, or myh9a and myh10
together, at the same concentration of morpholino used for single
knockdown, did not worsen or change the MHB phenotype observed
(data not shown). However, the double knockdown of myh9a and
myh9b did appear to worsen the gross whole embryo tail and eye
phenotypes at 24 ss, which is consistent with the localization ofmyh9a
gene expression at this time point (data not shown).
We rescued the 24 ss brain phenotypes in myh9b and myh10
morphants by co-injection of human MYH9 or MYH10 mRNA
(Fig. S3). Quantiﬁcation and representative images are shown for
normal, mild, and severe myh9b and myh10 morphant phenotypes
(Fig. S3). For all of the experiments presented here investigating MHB
defects and cell shape analysis, only mild phenotypes were analyzed.
This is consistent with the level of protein knockdown we detect
using the myh10 morpholino, where our knockdown results in
approximately 40% loss of the NMIIB protein (Fig. S1D). Together
these data demonstrate that knockdown of both myh9b and myh10,
but not myh9a knockdown, results in abnormal formation of the
MHB indicating a role for myh9b andmyh10 in brain morphogenesis.
More detailed and quantitative comparisons of the knockdown MHB
phenotypes are described in the following sections.
MHB tissue angle is dependent upon non-muscle myosin IIA and IIB
After determining that knockdown for both myh9b and myh10 led
to defects in MHB formation by brightﬁeld microscopy, we wanted
to determine the speciﬁc role for these non-muscle myosin proteins
in regulating cell and tissue shape during morphogenesis. We per-
formed detailed analyses on our non-muscle myosin II morphant
brains and compared them to control morpholino injected embryos.
We ﬁrst examined the MHB tissue angle. Single-cell embryos were
injected with MO and mGFP, and then imaged live using confocal
microscopy. The angle at the MHBC was measured and compared
(Fig. 3E–J). The average angle at 24 ss in control MO injected embryos
was approximately 100 degrees. myh9a morphants had a normal
tissue angle; however, myh9b MO injected embryos had a broader
tissue angle of 125 degrees, and myh10 MO injected embryos had
an abnormal MHB tissue angle of 140 degrees (Fig. 3E–J). These results
indicate that bothmyh9b andmyh10 contribute to the formation of the
tissue angle at the MHB. We also analyzed the tissue angle in mypt1
morphants. mypt1 is the regulatory subunit of myosin phosphatase
and mypt1 knockdown results in non-functional myosin phosphatase
and overactive non-muscle myosin II activity (Hartshorne et al., 2004).
In addition, our previous report demonstrated that mypt1 knockdown
leads to abnormal tissue and cell shape in the hindbrain (Gutzman and
Sive, 2010). With mypt1 knockdown, and therefore overactive NMIIA
and NMIIB, we found that themypt1morphants also had an abnormal
tissue angle with an average of 130 degrees at 24 ss (Fig. 3I–J). This
result further supports the observation that regulation of non-muscle
myosin activity is important for this morphogenetic process.
Since non-muscle myosin II is known to be required for normal
cell proliferation, we conﬁrmed that the brain phenotypes
observed were not a result of increased or decreased cell prolif-
eration or cell death. We analyzed cell proliferation with PH3
staining and cell death with TUNEL staining. We found that cell
proliferation and cell death were normal in myh9b and myh10
morphants at the concentrations of MO used for these experi-
ments (Fig. S4). Together, these results indicate that myh9b and
myh10 have critical roles in determining the proper angle of tissue
folding at the MHB, and thatmyh9a does not appear to be involved
in this process. The mypt1 knockdown phenotype also conﬁrms
the importance of speciﬁc regulation of the contractile state of the
NMII proteins during MHB morphogenesis.
myh9b is required for cell shortening at the MHBC
During MHB morphogenesis, the ﬁrst cell shape change occurs
between 17 and 22 h post fertilization (equivalent to 16 to 24 ss)
where cells at the MHBC shorten to 75% of the length of cells
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Fig. 3. myh9b,myh10, and mypt1 are required for MHB tissue morphogenesis. (A–D) Brightﬁeld dorsal view images of 24 ss embryos following injection with (A) control MO,
(B) myh9a MO, (C) myh9b MO, (D) myh10 MO. Anterior is to the left in all images. Arrowheads indicate MHBC. Scale bars: 100 mm. (E–I) Live confocal images showing the
MHB region of 24 ss zebraﬁsh embryos injected with mGFP mRNA and coinjected with control MO (E), myh9a MO (F), myh9b MO (G), myh10 MO (H), or mypt1 MO (I).
(J) Quantiﬁcation of the MHB angle on the basal side of the neuroepithelium (see angle lines in E–I). One-way ANOVA with multiple t-test comparisons was performed to
determine signiﬁcance between control and test groups. Asterisks indicate po0.001. Results are shown as7s.e.m. For E-I; control MO, n¼48; myh9aMO, n¼10; myh9bMO,
n¼16; myh10 MO, n¼18; mypt1 MO, n¼20.
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outside of the MHBC (Fig. 2 and Gutzman et al., 2008). The
mechanisms that regulate cell shortening at the MHBC are
unknown. We hypothesized that NMII proteins regulate this cell
shape change which is required for the formation of the normal
MHB tissue angle. We tested this hypothesis using knockdown
experiments and then quantifying the length of the cells at the
MHBC and outside of the MHBC (Fig. 4). Embryos were injected
with mGFP and speciﬁc morpholinos targeting myh9a, myh9b,
myh10, or mypt1, and then live imaged at 24 ss using confocal
microscopy. Cell length was quantiﬁed at the MHBC. At this stage
of development neuroepithelial cells span the entire epithelium
from apical to basal; therefore, we used the width of the single
layer of pseudostratiﬁed epithelium as a measure of cell length.
We measured cell length on one side of the neural tube at the
MHBC (X) (Fig. 4A). Then we measured the length of cells 40 μm
posterior to the MHBC (approximately 15 cells) outside of the
MHBC region (Y) (Fig. 4B). We found that myh9b morphants had
signiﬁcantly longer cells at the MHBC compared to controls,
while the length of the MHBC cells in myh9a and myh10
morphant cells were unchanged (Fig. 4C–G). In the surrounding
region posterior to the MHBC we found that cell length in myh9b
morphants was the same as control, but myh10 cells were
slightly, but signiﬁcantly, shorter (Fig. 4H). However, this small
change in cell length outside of the MHBC from myh10 mor-
phants would still not account for the dramatic angle change
observed at the MHBC.
At the MHBC, and outside of the MHBC, mypt1 morphant cells
were shorter than control cells (Fig. 4F, H). This observation
continues to support the role for mypt1 in regulating myosin
contraction. mypt1 morphants have overactive myosin, which
causes increasing actomyosin contraction within the cells and
leads to a shortening of the cells, consistent with the cell shape
phenotype previously observed in the hindbrain (Gutzman and
Sive, 2010).
Fig. 4. myh9b is required for cell shortening at the MHBC during morphogenesis. (A–F) Live confocal images showing the MHB region of 24 ss zebraﬁsh embryos injected
with mGFP and coinjected with control MO (A–B), myh9a MO (C), myh9b MO (D), myh10 MO (E), or mypt1 MO (F). (G) Quantiﬁcation of the cell length (X) at the MHBC (see
lines in A, C–F). (H) Quantiﬁcation of cell length 40 μm outside of the MHBC (Y) (see lines in B–F). One-way ANOVA with multiple t-test comparisons was performed to
determine signiﬁcance between control and test groups. Asterisks indicate po0.001. Double asterisks indicate po0.05. Results are shown as7s.e.m. Control MO, n¼48;
myh9a MO, n¼10; myh9b MO, n¼16; myh10 MO, n¼18; mypt1 MO, n¼20. Scale bars: 25 μm.
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Together these data indicate that cell shortening at the MHBC is
dependent upon the function of myh9b, and notmyh10, suggesting
a different role for these two non-muscle myosin proteins in
regulating cell shape changes during MHB morphogenesis.
myh10 is required for regulating cell width in the MHB
In our detailed analysis of wild type embryos we discovered
that cells throughout the MHB region become narrower during the
formation of the fold (Fig. 2). While conducting our knockdown
experiments and confocal imaging, we noticed that cells of the
MHB in some morpholino-injected embryos looked wider than in
control-injected embryos. Therefore, we conducted additional
quantiﬁcation of cell shapes by determining cell width and area
in the MHB neuroepithelium in knockdown embryos. Embryos
were injected with mGFP and morpholinos, and then live imaged
at 24 ss using confocal microscopy. We quantiﬁed cell width and
cell area in cells at the MHBC and in the posterior part of the MHB
(Fig. 5). We found that cells in the myh9a and myh9b morphants
had normal cell width and area (Fig. 5A–C, F, G); however, cells
from embryos injected with myh10 morpholino had signiﬁcantly
increased cell width and area (Fig. 5D, F, G). mypt1 morphants also
had signiﬁcant differences in cell area and width (Fig. 5E–G) as
would be predicted by over activation of non-muscle myosin and
as previously observed in the hindbrain (Gutzman and Sive, 2010).
These data indicate that myh10, and not myh9b, is critical for
the regulation and maintenance of cell width in the MHB region of
the neuroepithelium. This further supports the differential role for
myh9b and myh10 in regulating cell shape at the MHB.
Abnormal distribution of actin at the MHB with NMIIA and NMIIB
knockdown
The discovery that NMIIA and NMIIB have different roles in
regulating cell shape changes at the MHB led us to ask, what are the
mechanisms for this differential regulation? We have previously
demonstrated that later in MHB formation (24 hpf) actin is enriched
at the MHBC (Gutzman et al., 2008), and since we know that non-
muscle myosin proteins are actin motors, we asked whether or not
the distribution of actin in our knockdown embryos was also
differentially disrupted with NMIIA or NMIIB knockdown.
Embryos were injected with the morpholino indicated, stained
with phalloidin, and imaged using confocal microscopy to show
actin localization in the MHB region (Fig. 6). We quantiﬁed the
relative distribution of actin within the MHB in three regions. We
determined the amount of actin within the neuroepithelium at
the MHBC compared to the neuroepithelium outside the MHBC
Fig. 5. myh10 is required for regulation of cell width in the MHB during morphogenesis. (A–E) Live confocal images showing one side of the MHB region of 24 ss zebraﬁsh
embryos injected with mGFP and coinjected with control MO (A), myh9a MO (B), myh9b MO (C), myh10 MO (D), or mypt1 MO (E). Single representative cells are outlined in
each panel. (F) Quantiﬁcation of cell width. (G) Quantiﬁcation of cell area. One-way ANOVA with multiple t-test comparisons was performed to determine signiﬁcance
between control and test groups. Asterisks indicate po0.001. Double asterisks indicate po0.05. Results are shown as7s.e.m. 6 cells per embryo (n) were outlined: 2 cells at
the MHBC, 2 cells 40 μm posterior to the MHBC, and 2 cells within the 40 μm region between the MHBC and posterior. Cells were chosen based on the ability to see an entire
cell from apical to basal in a single z-section. Control MO, n¼9; myh9a MO, n¼9; myh9b MO, n¼14; myh10 MO, n¼9; mypt1 MO, n¼9. Scale bars: 25 μm.
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(Fig. 6A). We compared the amount of actin located apically at the
midline of the neural tube compared to the amount of actin within
the neuroepithelium at the apical edge of the MHBC cells (Fig. 6B),
and we compared the amount of actin located on the basal side of
the neural tube compared to the amount of actin within the
neuroepithelium at the basal edge of the MHBC cells (Fig. 6C).
These different regions of the neuroepithelium were used for
comparison in B and C to more carefully address changes at the
extreme apical or basal edges of the cells compared to just inside
the adjacent neuroepithelium. We used the ratio of mean ﬂuores-
cence intensity of actin staining in two regions within each
embryo for comparison, shown by box 1 and box 2 (Fig. 6A–C).
The actin mean intensity ratio for box 1 was divided by box 2 in that
given region. A ratio of 1 would indicate equal distribution of actin
in box 1 and box 2. In control embryos there is approximately
1.5 times more actin within the neuroepithelium at the MHBC
compared to more posterior neuroepithelium. This reﬂects the actin
distribution previously described (Gutzman et al., 2008). There is
two times more actin localized to the apical region of cells
compared to the adjacent apical side of the neuroepithelial cells,
and there is 1.5 times more actin on the basal side of the epithelium
compared to the adjacent basal side of the neuroepithelium in the
region of the MHBC (Fig. 6A–C, G). When we investigated actin
distribution with myh9b knockdown we found a decrease in actin
localization within the MHBC neuroepithelium and apically, while
basal actin was unchanged (Fig. 6D, G). With myh10 knockdown
there was a signiﬁcant decrease in actin localized to the MHBC
neuroepithelium, apically, and basally indicating that actin in all
areas of the MHBC cells was disrupted (Fig. 6E, G). mypt1 knock-
down did not affect apical actin distribution, as previously reported
in the hindbrain (Gutzman and Sive, 2010); however, actin within
the MHBC neuroepithelium was disrupted, as was basal actin
distribution (Fig. 6F–G). Together, the differences in actin distribu-
tion with myh9b knockdown compared to myh10 knockdown are
consistent with myh9b and myh10 having differential effects on
regulating the actin cytoskeleton and neuroepithelial cell shape
changes at the MHBC. myh9b affected actin only in the neuroe-
pithelium and apically at the midline, while myh10 affected actin
within the neuroepithelium, apically, and basally.
Non-muscle myosin IIA and IIB protein localization
We also hypothesized that NMIIA and NMIIB would be differ-
entially localized within the cells which could in turn explain their
ability to differentially regulate cell shape. In order to test this
hypothesis we used antibody staining speciﬁc for either NMIIA or
NMIIB to see their localization pattern within the MHB region
(Fig. 7). We did not detect any obvious differences between NMIIA
and NMIIB localization in control embryos (Fig. 7A–C). The
localization pattern was consistent with what has been demon-
strated in the mouse neural tube (Ma et al., 2007). We did,
however, see changes in both NMIIA and NMIIB localization with
mypt1 knockdown where non-muscle myosin II proteins accumu-
lated apically and basally in the neuroepithelium as seen pre-
viously for NMIIA (Fig. 7D and (Gutzman and Sive, 2010)).
Interestingly, when we stained for NMIIA with knockdown of
myh10 we found a change in NMIIA localization from generally
cytoplasmic and apical to more diffuse and basally localized
(Fig. 7E). We also found a change in NMIIB localization with
myh9b knockdown, again from mostly cytoplasmic to more diffuse
with increased basal localization (Fig. 7F). No primary controls are
shown to indicate the speciﬁcity of the staining (Fig. 7G–H).
These data indicate that normally, the localization of NMIIA and
NMIIB is overlapping within the neuroepithelium of the MHB region
at this time, suggesting that the mechanism by which NMIIA and
NMIIB are differentially regulating cell shape changes during brain
morphogenesis is not due to differential localization, but likely due to
differential regulation of activity. Furthermore, our analysis of loca-
lization of one NMII protein with knockdown of other indicates that
NMIIA and NMIIB depend on each other for proper localization.
Discussion
myh9b and myh10 differentially regulate cell shape during MHB
morphogenesis
In wild type embryos, the basal angle of the MHB changes over
time from 140 degrees at 18 ss to a more acute angle of 95 degrees
Fig. 6. Actin distribution is dependent upon non-muscle myosin II function. (A–F) Embryos were injected as indicated and stained with phalloidin (green) to determine actin
localization and regional enrichment. (A–C) Control morphant embryos with normal actin distribution at the MHB. Boxes indicate areas of comparison for determining the
mean actin intensity ratio. (A) Comparison of actin intensity with the neuroepithelium at the MHBC region (box 1) compared to the posterior MHB (box 2). (B) Comparison of
actin intensity apically at the midline (box 1) compared to the apical region within the neuroepithelial tissue (box 2). (C) Comparison of actin intensity on the basal side of
the neuroepithelium (box 1) compared to the basal region within the neuroepithelial tissue (box 2). (G) Quantiﬁcation of actin distribution comparison ratios for control MO,
myh9b MO, myh10 MO, and mypt1 MO injected embryos in the regions indicated. One-way ANOVA with multiple t-test comparisons was performed to determine
signiﬁcance between control and test groups. Results are shown as7s.e.m. Asterisks indicate signiﬁcance compared to control, po0.001. Double asterisks indicate, po0.01.
Arrowheads indicate MHBC. Control MO, n¼8; myh9b MO, n¼12; myh10 MO, n¼13; mypt1 MO, n¼8.
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by 24 ss (Fig. 2). During this time, cells at the MHBC are changing
shape to allow this angle to form. Cells at the MHBC shorten
by approximately 25%, while cells outside the MHBC also shorten
slightly over this time window (Fig. 2). Concurrently, cells thro-
ughout the MHB region become narrower between 22 ss and 24 ss
(Fig. 2). Together these morphogenetic changes lead to the for-
mation of the highly conserved MHB fold (Fig. 8A).
Here, we demonstrate for the ﬁrst time that non-muscle myosin
IIA and IIB have distinct roles in regulating cell shape changes during
brain morphogenesis. We discovered that NMIIA is required for the
shortening of the cells speciﬁcally at the MHBC, while NMIIB is
required for the narrowing of the cells throughout the MHB region
(Fig. 8B and C). In contrast to our knockdown studies, we investigated
non-muscle myosin II gain of function using mypt1 knockdown. We
found that cells in mypt1 morphants, where there is over activation
of non-muscle myosins, were both shorter and wider cells through-
out the MHB region (Fig. 8D), which is consistent with the cell shape
phenotype found with mypt1 loss of function in the hindbrain
(Gutzman and Sive, 2010). Together, these data demonstrate that
NMIIA is required for regulating the length of cells speciﬁcally at the
MHBC and not in surrounding regions, while NMIIB is required for
regulation of cell width throughout the MHB region. This uncovers a
novel differential role for mechanisms by which these two proteins
regulate cell shape during brain morphogenesis.
Cell length and cell width during development
Morphogenetic processes require speciﬁc changes in cell shape to
cause bending of epithelial sheets, tissue invagination, and tube
formation. We propose that regulating cell length and cell width may
be as important in developmental processes as apical constriction or
cell migration; however, investigation and quantiﬁcation of these
more subtle changes in cell shape has been limited. Apical constric-
tion results in decreased surface area on the apical side of the
polarized cell changing shape, and is critical in development during
gastrulation and vertebrate neural tube formation (Haigo et al., 2003;
Lee and Harland, 2007; Martin et al., 2009). Various mechanisms of
apical constriction have been described depending on cell type and
context, typically involving apical actomyosin networks linked to
cell-cell apical junctions (Martin and Goldstein, 2014). Other cell
shape changes including changes in cell length, width, or basal
constriction have been less well deﬁned and are likely to be
regulated through both overlapping and distinct mechanisms. For
example, during neural tube formation, cells of the neural plate have
been described to lengthen before they apically constrict (Karfunkel,
1974), and although this cell shape change has been deﬁned for
decades, the mechanism for this cell lengthening has not been
studied. Distinct mechanisms have been uncovered for regulation
of basal constriction. We determined that basal constriction at the
MHB, following cell shortening, is laminin dependent, and basal
constriction in optic cup morphogenesis requires the novel gene
ojoplano (Gutzman et al., 2008; Martinez-Morales et al., 2009; Wang
et al., 2012). In contrast, follicle cells in drosophila egg chamber
elongation are regulated by actomyosin contraction, as in apical
constriction; however, the orientation of the ﬁlaments is different
and the contraction occurs basally, not apically, to shape the tissue
(He et al., 2010).
The Kupffer's vesicle also undergoes regional cell shape
changes during development. Interestingly, in the Kupffer's vesicle
the anterior cells are elongated and the posterior cells shorten and
widen over time (Wang et al., 2012), cell shape changes that are
similar to those described here for MHB morphogenesis. Further-
more, these cell shape changes are regulated by non-muscle
myosin II activity (Wang et al., 2012); however, it was not
determined if NMIIA and NMIIB had distinct functions in the
shortening or widening of cells. Future experiments to determine
the mechanisms that regulate cell shape changes such as length,
width, and basal constriction are essential for understanding
complex morphogenetic processes.
Function of NMIIA versus NMIIB
The DNA sequence and protein structural similarities bet-
ween NMIIA and NMIIB might suggest that these proteins are
Fig. 7. Non-muscle myosin IIA and IIB protein localization. (A–C) NMIIA and NMIIB antibody staining in 24 ss embryos injected with control MO. (A) NMIIA antibody (green),
(B) NMIIB antibody (red), (C) overlay of A and B. (D) Overlay of NMIIA and NMIIB immunostaining in a 24 ss mypt1 MO injected embryo. (E) NMIIA staining with myh10 MO
knockdown. (F) NMIIB staining with myh9b MO knockdown. (G–H) No primary control from Alexa 488 and Alexa 555 secondary antibodies. Results are representative of at
least three independent experiments. Control MO, n¼8; mypt1 MO, n¼7; myh10 MO, n¼14; myh9b MO, n¼19; Alexa 488 no primary control, n¼5; Alexa 555 no primary
control, n¼5.
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redundant; however, it is becoming more apparent that each
isoform has distinct functions. The function of these proteins has
been determined using knockdown studies in many systems.
NMIIA and NMIIB knockout mice display different phenotypes,
where NMIIA knockouts are embryonic lethal due to cell adhesion
defects (Conti et al., 2004), and NMIIB knockouts present with
heart, brain, and neuronal migration defects (Ma et al., 2007; Ma
et al., 2004). The ablation of NMIIB in mice resulted in structural
abnormalities in the brain of mice, consistent with the role for
NMIIB neuroepithelial morphogenesis (Tullio et al., 2001). Experi-
ments to test for functional redundancy between NMIIA and
NMIIB have suggested only a limited ability for the proteins to
compensate for each other. For example, replacement of NMIIB
with NMIIA in the mouse rescues brain abnormalities, but does not
rescue cardiac defects (Bao et al., 2007). Here we have uncovered
new isoform-distinct functions in regulating cell shape at the MHB
during brain morphogenesis.
NMIIA and NMIIB have different enzymatic properties during
ATP-hydrolysis which determine their distinct roles in regulating cell
shape. Only a small fraction of the head domain of NMIIA is strongly
bound to actin at any one time (Kovacs et al., 2003). In contrast,
NMIIB is one of the slowest myosins with regard to the rate inwhich
it translocates actin ﬁlaments by having a slow ATPase cycle;
therefore it spends a signiﬁcantly longer time strongly bound to
actin (Wang et al., 2003). This longer binding may make NMIIB
better suited for maintaining cellular tension. These differences in
enzymatic activity may account for the role of NMIIB in regulating
cell width and area throughout the MHB region, while NMIIA is
working more quickly to shorten cells in a speciﬁc brain region.
Differential regulation of NMIIA and NMIIB
We determined that NMIIA and NMIIB proteins are not differ-
entially distributed within the cells at the MHB; however, we did
discover that knockdown of one can inﬂuence the localization of
the other (Fig. 7). NMIIA and NMIIB are both activated through
phosphorylation of the myosin regulatory light chain (MRLC)
(Bresnick, 1999; Ito et al., 2004). Yet, NMIIA and NMIIB are
differentially regulating cell shape in the same cell resulting in
distinct changes. From our previous work, we know that the level
of phosphorylated MRLC in the brain increases from 18 hpf to
21 hpf and then goes back down by 24 hpf (Gutzman and Sive,
2010), indicating the NMII activity is high in the brain during the
time of morphogenesis investigated here. MRLC activation can
occur through multiple signaling pathways; including through
myosin light chain kinase (MLCK) and/or Rho-kinase (ROCK). In
cell culture, MLCK and ROCK speciﬁcally localize to regulate MRLC
phosphorylation in a spatially dependent manner. In 3T3 cells,
ROCK is more active in phosphorylating MRLC at the center of the
cell, while MLCK is more active in phosphorylating MRLC at the
cell periphery (Totsukawa et al., 2004; Totsukawa et al., 2000). It
was demonstrated in migratory cells that a given cellular micro-
environment may play a role in determining the localization and
function of speciﬁc NMII isoforms (Raab et al., 2012). Although we
do not see a difference in NMIIA and NMIIB localization in normal
tissue here, potentially the differential function of the two proteins
is determined by differential localization of their upstream acti-
vators which have yet to be identiﬁed. Another possibility is that,
although the proteins are localized in the same parts of the cell,
Fig. 8. Model for non-muscle myosin IIA and IIB differential regulation of cell shape changes at the MHB during brain morphogenesis. (A) Representation of a wild-type or
control morphant embryo at 24 ss with magniﬁcation of the MHB region and simpliﬁed model of cell shape at the MHB. Wild-type and control morphants have an MHB
angle of approximately 100 degrees and cells at the MHBC are almost 25% shorter than surrounding cells, while all cells have equal cell width. (B) myh9b knockdown results
in an increase in the MHB angle to 125 degrees and this angle difference is due to cells speciﬁcally at the MHBC not shortening normally. (C)myh10 loss-of-function results in
an increase in the MHB angle to 140 degrees as a result of increase in cell width with normal cell length at the MHBC. (D) mypt1 knockdown, and increased activation of both
NMIIA and NMIIB, results in both shorter and wider cells throughout the region leading to an increase in the MHB angle to 130 degrees.
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the orientation of the non-muscle myosin heavy chains may be
oriented in opposing directions. For example, NMIIA ﬁbers may
run in an apical to basal direction to regulate cell length, while
NMIIB ﬁbers may orient perpendicularly to NMIIA to regulate
cell width.
Non-muscle myosin heavy chains IIA and IIB can both be
phosphorylated on various sites to affect ﬁlament assembly and
protein function (Vicente-Manzanares et al., 2009). This raises
the question as to whether or not there is a difference in the
phosphorylation state of the non-muscle myosin heavy chains
themselves at the MHB. Phosphorylation of the NMII heavy chains
facilitates ﬁlament disassembly and NMIIA and NMIIB have differ-
ent sites in their tail domains making this a possible level of
differential activation and regulation. It was also recently demon-
strated that NMII isoforms can co-assemble in living cells, forming
heterotypic ﬁlaments that can perform both isoform speciﬁc and
redundant functions (Beach et al., 2014). It remains to be seen if
these heterotypic ﬁlaments are present in the neuroepithelium
during development.
Differential distribution of actin with non-muscle myosin knockdown
It is established that NMII protein activity, in response to extra
or intra-cellular signals, contributes to the spatial organization of
the actin network, resulting in contractility and physiological
functions (Kohler et al., 2011). Both NMIIA and NMIIB knockdown
resulted in abnormal actin distribution in the MHB region during
morphogenesis. Knockdown of NMIIA caused changes in actin
localization within the neuroepithelium and at the apical surface
of the neural tube, while knockdown of NMIIB caused abnormal
actin distribution within the neuroepithelium, and at both the
apical and basal surfaces of the neural tube. The location of actin
affected by NMII knockdown may provide some additional clues as
to the regulation of the NMII protein. Since mypt1 appears to
regulate NMII activity apically, it is likely to be regulating both
NMIIA and NMIIB (Gutzman and Sive, 2010), which is consistent
with the mypt1 knockdown cell shape phenotypes as well.
Actomyosin activity is regulated on the basal surface of follicle
cells by Rho, ROCK, and cell-cell adhesion during Drosophila egg
chamber development to cause contraction (He et al., 2010).
However, Drosophila have only one non-muscle myosin heavy
chain (zipper), indicating the importance for in vivo vertebrate
studies to determine how NMIIA and NMIIB are differentially
regulating cell shape. These studies will be essential to elucidate
additional mechanisms of morphogenetic processes.
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